Moulin Chokshi, MD
Clinical Cardiac Electrophysiology · Wallingford, CTNPI 1790074508
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $9,932 of the $16,507 with a category attached, or 60.2%. 27 manufacturers reported payments, led by Boston Scientific at 27.0% of the total. Reporting peaked in 2021 at $6,113 and has fallen 88.7% since, to $691 in 2025. That places this record below the midpoint for clinical cardiac electrophysiology clinicians in CT, where the typical reported total is $16,507.
Across 318 payments — averaging $51.91 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$4K
- Abbott$3K
- Biotronik Inc.$2K
- Medtronic$1K
- Johnson & Johnson$1K
- Novartis$973
- plus $3K from 21 others
What the payments were for
- Consulting fees$4002%
- Grants$3,97124%
- Travel & lodging$2,20413%
- Food & beverage$9,93260%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 8 | $4,455 |
| Abbott | 31 | $3,120 |
| Biotronik Inc. | 12 | $2,302 |
| Medtronic(2 entities) | 30 | $1,392 |
| Johnson & Johnson | 62 | $1,163 |
| Novartis | 53 | $973 |
| AstraZeneca | 7 | $433 |
| Pfizer | 23 | $406 |
| ZOLL Services LLC (a/k/a ZOLL Lifecor Corp) | 9 | $364 |
| Biosense Webster, Inc. | 10 | $356 |
| E.r. Squibb & Sons, L.L.C. | 14 | $276 |
| Cardiva Medical, Inc. | 12 | $233 |
| Amgen | 11 | $223 |
| Boehringer Ingelheim | 7 | $169 |
| Esperion Therapeutics, Inc. | 5 | $104 |
| Sanofi-aventis U.S. LLC | 4 | $89 |
| Novo Nordisk | 3 | $78 |
| Amarin Pharma, Inc. | 4 | $59 |
| Stryker | 1 | $53 |
| Alnylam Pharmaceuticals Inc. | 2 | $41 |
| Jazz Pharmaceuticals Inc. | 1 | $39 |
| Merck | 2 | $38 |
| Atricure, Inc. | 1 | $36 |
| Impulse Dynamics (USA) Inc. | 2 | $33 |
| Bardy Diagnostics, Inc. | 2 | $26 |
| Bayer | 1 | $26 |
| Harmony Biosciences LLC | 1 | $21 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- GENERAL BRADY$2,500
- Acticor$2,015
- Edora$2,015
- BioMonitor$2,015
- Rivacor$2,015
- Solia$2,015
- EnSite Precision Cardiac Mapping System$1,324
- GENERAL TACHY$901
- GENERAL EP$570
- GALLANT$400
- FARXIGA$231
- GENERAL - THERAPIES$196
- Micra$174
- COBALT DR MRI SURESCAN$167
- PulseSelect$157
- Confirm Rx$150
- Assurity Pacemaker$143
- Fortify Assura, Ellipse ICD$134
- WAINUA$123
- XARELTO$107
How this compares
$16,507 in reported general payments places this provider in the 50th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.
See all clinical cardiac electrophysiology providers in Connecticut →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| MultaqDronedarone Hcl | 34 | $39,855 |
| EliquisApixaban | 23 | $31,196 |
| Mexiletine Hcl | 38 | $2,243 |
| Flecainide Acetate | 40 | $1,295 |
| Amiodarone Hcl | 40 | $1,133 |
| Metoprolol Succinate | 73 | $653 |
| Doxycycline Monohydrate | 32 | $343 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 24 | $277 |
| Pantoprazole Sodium | 21 | $138 |
| Metoprolol Tartrate | 21 | $101 |
| Doxycycline Hyclate | 12 | $83 |
| Furosemide | 17 | $10 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Sanofi-aventis U.S. LLCMultaq | $89 | $39,85534 claims |
| PfizerEliquis | $406 | $31,19623 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 47 clinical cardiac electrophysiology providers in Connecticut.
Other clinical cardiac electrophysiology in Wallingford
- Joseph Dell OrfanoHartford$160K
- Paras BhattNorwich$139K
- Steven ZweibelHartford$125K
- Murali ChiravuriFairfield$101K
- James FreemanNew Haven$87K
- Jude ClancyMiddletown$84K
- Joseph TianoTrumbull$70K
- Michael PittaroStamford$70K
- Neal LippmanHartford$69K
- Mark MariebHamden$54K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.